Jade Biosciences Ownership | Who Owns Jade Biosciences?
Jade Biosciences Ownership Summary
Jade Biosciences is owned by 134144.16% institutional investors, 0.04% insiders. Fmr is the largest institutional shareholder, holding 17.20% of JBIO shares.
JBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Jade Biosciences | 134144.16% | 0.04% | -134044.20% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 4.89M | 17.20% | $42.19M |
| Vr adviser | 3.22M | 11.33% | $27.79M |
| Fairmount funds management | 3.22M | 11.33% | $27.79M |
| Deep track capital, lp | 2.28M | 8.02% | $19.68M |
| Blackrock funding, inc. /de | 2.15M | 7.56% | $18.56M |
| Vanguard group | 1.73M | 6.07% | $14.90M |
| Versant venture management | 1.53M | 5.37% | $13.17M |
| Rtw investments, lp | 1.45M | 5.10% | $12.51M |
| Frazier life sciences management | 1.41M | 4.97% | $12.20M |
| Driehaus capital management | 1.26M | 4.42% | $10.84M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 1.53M | 6.20% | $13.17M |
| Fairmount funds management | 3.22M | 2.50% | $27.79M |
| Great point partners | 632.60K | 2.25% | $5.46M |
| Avidity partners management lp | 1.13M | 2.21% | $9.73M |
| Vr adviser | 3.22M | 1.56% | $27.79M |
| Samsara biocapital | 531.16K | 0.60% | $4.58M |
| Deep track capital, lp | 2.28M | 0.55% | $19.68M |
| Logos global management lp | 625.00K | 0.48% | $5.39M |
| Frazier life sciences management | 1.41M | 0.37% | $12.20M |
| Soleus capital management | 796.74K | 0.35% | $6.88M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 2.15M | 0.00% | 435.86K |
| State street | 499.29K | 0.00% | 180.52K |
| Goldman sachs group | 162.71K | 0.00% | 162.71K |
| Great point partners | 632.60K | 2.25% | 134.54K |
| Wellington management group llp | 107.55K | 0.00% | 107.55K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Frazier life sciences management | 1.41M | 0.37% | -358.84K |
| Deep track capital, lp | 2.28M | 0.55% | -229.41K |
| Barclays | 45.77K | 0.00% | -229.06K |
| Woodline partners lp | - | - | -106.27K |
| Vanguard group | 1.73M | 0.00% | -80.84K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Goldman sachs group | 162.71K | 0.00% | 162.71K | $1.40M |
| Wellington management group llp | 107.55K | 0.00% | 107.55K | $928.18K |
| Marshall wace, llp | 38.08K | 0.00% | 38.08K | $328.63K |
| Invesco | 34.58K | - | 34.58K | $298.39K |
| Two sigma investments, lp | 24.61K | 0.00% | 24.61K | $212.38K |
Sold Out
| Holder | Change |
|---|---|
| Glenmede investment management, lp | -53.00 |
| Cwm | -120.00 |
| Tcg crossover management | -64.02K |
| Woodline partners lp | -106.27K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 32 | - | 6,707,208 | - | 134,144 | - | 32 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Frohlich Tom | Chief Executive Officer | Buy | $44.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
JBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools